Zai Lab Shares Drop 9.8% as Zoci Phase 1b Results Spark Investor Optimism
Explore Zai Lab’s market dip, 250 M$ capital raise, and breakthrough Phase 1b zoci results—what this means for investors and the oncology sector.
3 minutes to read
ZAI LAB LTD